About half of our reviews are cited in guidelines and have made significant impact upon policy making. These range from NICE, in the UK, to WHO, globally.
National Collaborating Centre for Primary Care; National Institute for Health and Care Excellence (commissioner). Identification and management of familial hypercholesterolaemia (FH). London: Royal College of General Practitioners. [Updated November 2017. (NICE CG71).
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al.; European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 2017 September;38(36):2739–2791. doi:10.1093/eurheartj/ehx391.
National Clinical Guidelines Centre, National Institute for Health and Care Excellence (commissioner). Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Institute for Health and Care Excellence; 2014 (NICE CG181). [Issued July 2014, updated September 2016].
Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, et al. 2016 Canadian Cardiovascular Society Guidelines for the management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can J Cardiol. 2016 doi: 10.1016/j.cjca.2016.07.510.